从口腔衰老到全身慢性病: 牙周组织衰老与常见慢性病的关联机制及防治进展*

温琳琳 ,  孙宏晨

国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 396 -403.

PDF (1260KB)
国际老年医学杂志 ›› 2026, Vol. 47 ›› Issue (6) : 396 -403. DOI: 10.3969/j.issn.1674-7593.2026.06.001
专家论坛

从口腔衰老到全身慢性病: 牙周组织衰老与常见慢性病的关联机制及防治进展*

作者信息 +

From oral aging to systemic chronic diseases: mechanisms and management of periodontal tissue aging and common chronic conditions

Author information +
文章历史 +
PDF (1289K)

摘要

牙周组织衰老是增龄性退变与炎症性衰老共同驱动的复杂病理过程, 是连接口腔健康与全身慢性病的重要纽带。 牙周组织衰老通过炎症介质全身循环、 微生物及其毒力因子作用、 免疫防御损伤等途径, 驱动心血管疾病、 恶性肿瘤、 代谢性疾病及慢性呼吸系统疾病等重要慢性病的发生与进展。 重视牙周的预防可以降低慢性病发病风险, 规范的牙周治疗有助于延缓慢性病病程。 本文对牙周组织衰老影响上述慢性病的作用机制和防治的最新研究进展进行综述, 为进一步探索以口腔健康为靶点的慢性病防控策略提供研究思路。

Abstract

Periodontal tissue aging is a complex pathological process driven by both age-related degenerative changes and inflammaging, and represents a critical nexus between oral health and systemic chronic diseases. Through mechanisms including the inflammatory mediators in blood circulation, the translocation of oral microorganisms and their virulence factors, and the impairment of host immune defenses, aging periodontal tissues may contribute to the initiation and progression of major chronic conditions, including cardiovascular disease, malignancies, metabolic disorders, and chronic respiratory diseases. Improved periodontal prevention may reduce the risk of developing these chronic conditions, while standardized periodontal therapeutic interventions may help delay their clinical progression. This review summarizes the latest advances in the mechanisms linking periodontal tissue aging to the aforementioned chronic diseases and the corresponding preventive and therapeutic strategies, aiming to provide insights for future research on oral health-targeted chronic disease prevention and management.

关键词

口腔 / 牙周组织衰老 / 慢性病 / 炎症介质

Key words

Oral cavity / Periodontal tissue aging / Chronic conditions / Inflammatory mediators

引用本文

引用格式 ▾
温琳琳,孙宏晨. 从口腔衰老到全身慢性病: 牙周组织衰老与常见慢性病的关联机制及防治进展*[J]. 国际老年医学杂志, 2026, 47(6): 396-403 DOI:10.3969/j.issn.1674-7593.2026.06.001

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

Glavina A, Marti D, Perko M A, et al. The oral microbiome and systemic health: current insights into the mouth-body connection[J]. Life, 2026, 16(2): 294.

[2]

Cheng J, Aung C T Z, Suslavich S F, et al. From senescence and inflammaging to systemic comorbidities: drivers of aging-associated periodontitis [J]. Periodontol 2000, 2026 . doi: 10. 1111/ prd. 70049.

[3]

Romandini M, Hajishengallis G, Curtis M, et al. Periodontal medicine rewired: mechanisms linking periodontitis to systemic diseases[J]. J Periodontal Res, 2026, 61 (4). doi: 10. 1111/ jre. 70099.

[4]

Orlandi M, Graziani F, D’Aiuto F . Periodontal therapy and cardiovascular risk[J]. Periodontol 2000, 2020, 83 (1): 107-124.

[5]

Kotronia E, Wannamethee S G, Papacosta A O, et al. Poor oral health and inflammatory, hemostatic, and cardiac biomarkers in older age: results from two studies in the UK and USA[J]. J Gerontol Ser A, 2021, 76(2): 346-351.

[6]

Lo S C, Wang Y F, Deng X L . Periodontitis-induced systemic multi-organ aging mediated by the NF-κB signaling pathway[J]. Chin J Dent Res, 2025, 28(3): 173-184.

[7]

Miyauchi S, Kawada-Matsuo M, Furusho H, et al. Atrial translocation of Porphyromonas gingivalis Exacerbates atrial fibrosis and atrial fibrillation[J]. Circulation, 2025, 151(21): 1527-1540.

[8]

Yin S, Qiao Q, Li Z, et al. Porphyromonas gingivalis-derived outer membrane vesicles promote vascular endothelial glycocalyx injury via the PPAD/ CitH3/ B3GAT1 pathway[J]. J Nanobiotechnol, 2026, 24(1): 137.

[9]

Ebersole J L, Graves C L, Gonzalez O A, et al. Aging, inflammation, immunity and periodontal disease[J]. Periodontol 2000, 2016, 72(1): 54-75.

[10]

Baima G, Minoli M, Michaud D S, et al. Periodontitis and risk of cancer: mechanistic evidence[J]. Periodontol 2000, 2024, 96(1): 83-94.

[11]

Bogdan-Andreescu C F, Albu D, Sl􀅢vescu D A, et al. Periodontitis-induced immune reprogramming: implications for cancer immunotherapy response [J]. Biomedicines, 2026, 14(2): 480.

[12]

Wang S, Nie F, Yin Q, et al. Periodontitis promotes tumor growth and immune evasion via PD-1/ PD-L1[J]. Cancer Immunol Immunother, 2024, 74(1): 22.

[13]

Chauca-Bajaña L, Ordoñez Balladares A, Lorenzo-Pouso A I, et al. Periodontitis and oral pathogens in colorectal cancer: a systematic review, meta-analysis, and trial sequential analysis[J]. Dent J, 2025, 13(12): 595.

[14]

Villalobos V, Garrido M, Reyes A, et al. Aging envisage imbalance of the periodontium: a keystone in oral disease and systemic health[J]. Front Immunol, 2022, 13: 1044334.

[15]

Minty M, Canceil T, Serino M, et al. Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases[J]. Rev Endocr Metab Disord, 2019, 20 (4): 449-459.

[16]

Song X, Yue Z, Fan L, et al. Relationship between circulating senescence-associated secretory phenotype levels and severity of type 2 diabetes-associated periodontitis: a cross-sectional study[J]. J Periodontol, 2023, 94(8): 986-996.

[17]

Su Y, Ye L, Hu C, et al. Periodontitis as a promoting factor of T2D: current evidence and mechanisms[J]. Int J Oral Sci, 2023, 15: 25.

[18]

Jepsen S, Suvan J, Deschner J . The association of periodontal diseases with metabolic syndrome and obesity[J]. Periodontol 2000, 2020, 83(1): 125-153.

[19]

Gomes-Filho I S, Oliveira M T, da Cruz S S, et al. Periodontitis is a factor associated with dyslipidemia[J]. Oral Dis, 2022, 28(3): 813-823.

[20]

Thouvenot K, Turpin T, Taïlé J, et al. Links between insulin resistance and periodontal bacteria: insights on molecular players and therapeutic potential of polyphenols [J]. Biomolecules, 2022, 12(3): 378.

[21]

Kuraji R, Sekino S, Kapila Y, et al. Periodontal disease-related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: an emerging concept of oral-liver axis[J]. Periodontol 2000, 2021, 87(1): 204-240.

[22]

Zhang Z, Zheng Q, Liu Y, et al. Association between periodontitis and mortality in participants with metabolic dysfunction-associated steatotic liver disease: results from NHANES[J]. BMC Oral Health, 2025, 25(1): 567.

[23]

Aizenbud I, Wilensky A, Almoznino G . Periodontal disease and its association with metabolic syndrome-a comprehensive review [ J ]. Int J Mol Sci, 2023, 24 (16): 13011.

[24]

Niu C, Lv W, Zhu X, et al. Intestinal translocation of Live Porphyromonas gingivalis drives insulin resistance [J]. J Dent Res, 2024, 103(2): 197-207.

[25]

Liu X, Shi F, Zeng J, et al. Oral microbiota and respiratory diseases: advances and perspectives[J]. Clin Microbiol Rev, 2025, 38(2): e00150-e00124.

[26]

Wang D, Dai L, Cui Z, et al. Association between periodontal diseases and chronic obstructive pulmonary disease: evidence from sequential cross-sectional and prospective cohort studies based on UK Biobank[J]. J Clin Periodontol, 2024, 51(1): 97-107.

[27]

Qian Y, Yuan W, Mei N, et al. Periodontitis increases the risk of respiratory disease mortality in older patients [J]. Exp Gerontol, 2020, 133: 110878.

[28]

Mammen M J, Scannapieco F A, Sethi S . Oral-lung microbiome interactions in lung diseases [J]. Periodontol 2000, 2020, 83(1): 234-241.

[29]

Zhang L, Tian H, Ma Y, et al. Periodontitis pathogen Porphyromonas gingivalis promotes chronic obstructive pulmonary disease via affecting neutrophils chemotaxis and function[J]. Int J Oral Sci, 2026, 18: 4.

[30]

Ye H L, Meng X Q, Li H, et al. Periodontitis aggravates pulmonary fibrosis by Porphyromonas gingivalis-promoted infiltration of neutrophils and Th17 cells[J]. Front Cell Infect Microbiol, 2025, 15: 1595500.

[31]

Arango Jimenez N, Morales Vera D Z, Latorre Uriza C, et al. Relationship of obstructive sleep apnea with periodontal condition and its local and systemic risk factors [J]. Clin Oral Investig, 2023, 27(6): 2823-2832.

[32]

Lopes M P, Cruz Á A, Xavier M T, et al. Prevotella intermedia and periodontitis are associated with severe asthma[J]. J Periodontol, 2020, 91(1): 46-54.

[33]

Gomes-Filho I S, Passos J S, Seixas da Cruz S . Respiratory disease and the role of oral bacteria[J]. J Oral Microbiol, 2010, 2(1): 5811.

[34]

Worthington H V, MacDonald L, Poklepovic Pericic T, et al. Home use of interdental cleaning devices, in addition to toothbrushing, for preventing and controlling periodontal diseases and dental caries[J]. Cochrane Database Syst Rev, 2019, 4(4): CD012018.

[35]

Huang C, Shi G . Smoking and microbiome in oral, airway, gut and some systemic diseases[J]. J Transl Med, 2019, 17(1): 225.

[36]

Suvan J E, Sabalic M, Araújo M R, et al. Behavioral strategies for periodontal health [J]. Periodontol 2000, 2022, 90(1): 247-261.

[37]

Grant W B, van Amerongen B M, Boucher B J . Periodontal disease and other adverse health outcomes share risk factors, including dietary factors and vitamin D status [J]. Nutrients, 2023, 15(12): 2787.

[38]

Luthra S, Orlandi M, Hussain S B, et al. Treatment of periodontitis and C-reactive protein: a systematic review and meta-analysis of randomized clinical trials[J]. J Clin Periodontol, 2023, 50(1): 45-60.

[39]

da Silva Barbirato D, Nogueira N S, Guimarães T C, et al. Improvement of post-periodontitis-therapy inflammatory state in diabetics: a meta-analysis of randomized controlled trials[J]. Clin Oral Investig, 2024, 28(9): 514.

[40]

Krajewski A, Perussolo J, Ercal P, et al. The effect of non-surgical periodontal therapy on subgingival microbiota: a systematic review and meta-analysis[J]. J Periodontal Res, 2025, 60(10): 963-993.

[41]

Surma S, Lip G Y H . Periodontitis and atrial fibrillation [J]. Eur J Prev Cardiol, 2025: zwaf626.

[42]

Røsland A, Bertelsen R J, Heinrich J, et al. Effect of periodontal therapy on lung function: a twelve-month follow-up intervention study [J]. Respir Res, 2025, 26 (1): 172.

[43]

Koidou V P, Hagi-Pavli E, Nibali L, et al. Elucidating the molecular healing of intrabony defects following non-surgical periodontal therapy: a pilot study[J]. J Periodontal Res, 2024, 59(1): 53-62.

[44]

Duran-Pinedo A E, Solbiati J, Teles F, et al. Subgingival host-microbiome metatranscriptomic changes following scaling and root planing in grade Ⅱ/ Ⅲ periodontitis[J]. J Clin Periodontol, 2023, 50(3): 316-330.

[45]

Pietrzko M M, Pietrzko M, Niemczyk W, et al. Subgingival delivery of statins as an adjunct in the non-surgical treatment of periodontitis: a systematic review[J]. Bio-medicines, 2025, 13(1): 182.

[46]

Guzmán-Esquivel J, Garcia-Garcia H S, Hernández-Fuentes G A, et al. The impact of doxycycline as an adjunctive therapy on prostate-specific antigen, quality of life, and cognitive function in metastatic prostate cancer patients: a phase Ⅱ randomized controlled trial [J]. Pharmaceutics, 2025, 17(4): 404.

[47]

Ye X, Wang Y, Tian Y, et al. Metformin alleviates junctional epithelium senescence via the AMPK/ SIRT1/ autophagy pathway in periodontitis induced by hyperglycemia[J]. Heliyon, 2024, 10(6): e27478.

[48]

Bensman T J, Nguyen A N, Rao A P, et al. Doxycycline exhibits anti-inflammatory activity in CF bronchial epithelial cells [J]. Pulm Pharmacol Ther, 2012, 25 (5): 377-382.

[49]

Rattanaprukskul K, Xia X J, Hysa M, et al. Dasatinib and quercetin limit gingival senescence, inflammation, and bone loss [ J ]. J Dent Res, 2025, 104 (4 ): 419-427.

[50]

Fahim S M, Miah M, Marcotte M, et al. Saliva as a matrix for primary care: feasibility and scoping of its use for assessment of nutrition and inflammation[J]. Adv Nutr, 2026, 17(5): 100625.

基金资助

*国家自然科学基金区域创新发展联合基金重点支持项目(U25A2095)

AI Summary AI Mindmap
PDF (1260KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉